The tumor suppressor PTEN dephosphorylates phosphatidylinositol-3,4,5-trisphosphate to generate phosphatidylinositol-4,5-diphosphate, antagonizing PREX2 activity (24) and PI3K/AKT signaling. Here, PTEN is linked to neoplasm.